Severe rash after dermatitis
Buccolo, L.S.
Journal of Family Practice 53(8): 613-615
2004
ISSN/ISBN: 0094-3509 PMID: 15298825 Document Number: 567784
Document emailed within 1 workday
Related Documents
Levy, M. 2001: Diaper rash syndrome or dermatitis Cutis 67(5 Suppl): 37-38Miller, R.A.; McGrann, J.; Jassim, A.D.; Miller, T.N. 2010: Acute vesiculopapular rash in the setting of atopic dermatitis South Dakota Medicine: the Journal of the South Dakota State Medical Association 63(12): 407-409
Bonny, S.; Jagirdar, N.; Khan, S.; Bene, J. 2008: A severe rash Acute Medicine 7(1): 45
Danielsen, A.G.; Thomsen, J.S.; Svejgaard, E.L.øe. 2006: Severe skin rash in patients treated with terbinafine Ugeskrift for Laeger 168(44): 3825-3826
Wisuthsarewong, W.; Viravan, S. 2002: Management of severe atopic dermatitis with thymostimulin Journal of the Medical Association of Thailand 85(Suppl): S749-S754
Tan, A.U.; Gonzalez, M.E. 2012: Management of severe atopic dermatitis in children Journal of Drugs in Dermatology: Jdd 11(10): 1158-1165
Korstanje, M.J.; van de Staak, W.J. 1991: Cyclosporin maintenance therapy for severe atopic dermatitis Acta Dermato-Venereologica 71(4): 356-357
Bodemer, C. 2005: How should severe and chronic atopic dermatitis in children be managed? Annales de Dermatologie et de Venereologie 132(Special Issue 1): 1s121-1s130
Farshidi, A.; Sadeghi, P. 2006: Successful treatment of severe refractory atopic dermatitis with efalizumab Journal of Drugs in Dermatology: Jdd 5(10): 994-998
Lee, S.S.; Tan, A.W.H.; Giam, Y.C. 2004: Cyclosporin in the treatment of severe atopic dermatitis: a retrospective study Annals of the Academy of Medicine Singapore 33(3): 311-313
Vossbeck, S.; Knobloch, C.; Heymer, B.; Hartmann, W.; Friedrich, W. 1992: Severe combined immune defect. Presentation of exfoliative dermatitis with eosinophilia and lymphadenopathy Monatsschrift Kinderheilkunde: Organ der Deutschen Gesellschaft für Kinderheilkunde 140(3): 188-193
Wong, S.S. 1995: Permanent remission of severe atopic dermatitis in a Chinese patient after cyclosporin A therapy Acta Dermato-Venereologica 75(2): 168
2003: Calcineurin inhibitors in treatment of atopic dermatitis. Topical corticoids now only in severe outbreaks? MMWFortschrittederMedizin 145(29-30): 62
Cordero Miranda, M.A.; Flores Sandoval, G.; Orea Solano, M.; Estrada Parra, S.; Serrano Miranda, E. 1999: Safety and efficacy of treatment for severe atopic dermatitis with cyclosporin a and transfer factor Revista Alergia Mexico 46(2): 49-57
Singalavanija, S.; Noppakun, N.; Limpongsanuruk, W.; Wisuthsarewong, W.; Aunhachoke, K.; Chunharas, A.; Wananukul, S.; Akaraphanth, R. 2006: Efficacy and safety of tacrolimus ointment in pediatric Patients with moderate to severe atopic dermatitis Journal of the Medical Association of Thailand 89(11): 1915-1922
Rietmeijer, C.A.; Cohn, D.L. 1988: Severe allergic contact dermatitis from dinitrochlorobenzene in a patient with human immunodeficiency virus infection Archives of Dermatology 124(4): 490-491
Sugarman, J.L.; Parish, L.C. 2009: Efficacy of a lipid-based barrier repair formulation in moderate-to-severe pediatric atopic dermatitis Journal of Drugs in Dermatology: Jdd 8(12): 1106-1111
Niwa, Y.; Tominaga, K.; Yoshida, K. 1998: Successful treatment of severe atopic dermatitis-complicated cataract and male infertility with a natural product antioxidant International Journal of Tissue Reactions 20(2): 63-69
Saple, D.G.; Torsekar, R.G.; Pawanarkar, V.; Wali, V.; Ravichandran, G.; Dhanalakshmi, U.R.; Dongre, N.; Ballary, C.; Desai, A. 2003: Evaluation of the efficacy, safety and tolerability of Tacrolimus ointment in Indian patients of moderate to severe atopic dermatitis: a multicentric, open label, phase IIi study Indian Journal of Dermatology Venereology and Leprology 69(6): 396-400
Krueger, G.G.; Eichenfield, L.; Goodman, J.J.; Krafchik, B.R.; Carlin, C.S.; Pang, M.-L.; Croy, R.; Holum, M.E.; Jaracz, E.; Sawamoto, T.; Keirns, J. 2007: Pharmacokinetics of tacrolimus following topical application of tacrolimus ointment in adult and pediatric patients with moderate to severe atopic dermatitis Journal of Drugs in Dermatology: Jdd 6(2): 185-193